KISS1 / GPR54 Hypothalamic Peptide · Reproductive Axis · Protocol Guide
Kisspeptin: The Honest Reproductive Desire Peptide Guide
Kisspeptin is the upstream switch of the human reproductive axis. It tells GnRH neurons to fire, which raises LH, FSH, and downstream sex hormones. Unusually for a sexual-health peptide, it has real human trial data: brain-imaging studies from Imperial College London showing it shifts sexual and emotional processing. This guide draws the line between what those trials showed and what they did not.
- FDA Status
- Investigational, 503A Compounded
- Pharmacy
- Optimal Balance Pharmacy (503A licensed)
- Medical Service
- RxPepsDirect, physician-supervised
- Access
- 28 U.S. States
Our promise: Kisspeptin has better human evidence than most sexual-health peptides, but it is a specific kind of evidence: short intravenous-infusion brain-imaging studies, not long-term self-injected desire trials. The published work shows changed brain activity and, in the latest study, increased penile tumescence in men with low desire. It does not yet show that a take-home injection schedule produces a durable real-world libido benefit. We separate those two things clearly.
Medically reviewed by Dr. Jonathan Snipes, MD. Last reviewed June 8, 2026.On this page
Section 01
What Kisspeptin Actually Is
Kisspeptin is a naturally occurring peptide hormone encoded by the KISS1 gene. Its job in the body is to act as the master upstream switch of human reproduction. It binds a receptor called GPR54 (also written KISS1R) on the gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus, and when it does, those neurons fire. That single step sits at the top of the entire reproductive cascade.
Once GnRH neurons fire, the pituitary releases luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and those in turn drive the gonads to produce testosterone in men and estrogen and progesterone in women. In other words, kisspeptin does not replace your sex hormones the way exogenous testosterone does. It tells your own axis to turn itself up. This is why it gets described as working with the body's natural hormonal machinery rather than around it.
What makes kisspeptin genuinely interesting for sexual health is a second finding layered on top of the hormone story. A research group at Imperial College London, led by Waljit Dhillo, used functional brain imaging to show that kisspeptin does not only raise hormones, it also changes activity in the limbic and sexual-processing networks of the human brain. That puts it in a rare category: a sexual-health peptide with actual, published, placebo-controlled human data.
KISS1
The gene encoding kisspeptin, the upstream trigger of the reproductive axis
GPR54
The receptor (KISS1R) kisspeptin binds on GnRH neurons to start the cascade
3
Placebo-controlled human brain-imaging trials from the Imperial College London group
503A
Pathway for U.S. compounded access under physician prescription
Section 02
Who It Is Actually For
Kisspeptin is studied as a reproductive-axis and desire molecule. The populations below range from the actual trial groups to reasonable but unproven inferences, and the honest framing matters because the evidence is specific.
| Profile | Primary Motivation | Evidence Basis | Fit |
|---|---|---|---|
| Low Sexual Desire (HSDD), Men or Women | Restore desire and arousal through the reproductive axis | The actual trial populations. Placebo-controlled brain-imaging RCTs in both sexes. | Best Studied |
| General Libido Support, Healthy Adults | Boost desire and sex-hormone tone | Healthy-volunteer brain-imaging data exists, but not long-term real-world libido outcomes. | Moderate Fit |
| Fertility / Reproductive Support | Stimulate the LH and FSH axis | Mechanistically central and studied in reproductive medicine, but this is a specialist context. | Provider-Directed |
| Hormone-Optimization Add-On | Stack onto a broader testosterone or wellness plan | Plausible from the axis mechanism, not directly trialed as a stack. | Speculative |
| Pregnant or Possibly Pregnant | Any reason | Contraindicated. Kisspeptin is a central reproductive driver and is very high in pregnancy already. | Do Not Use |
| Athlete Subject to Anti-Doping Testing | Recovery or hormonal support during training | Testosterone-stimulating peptide, named on the WADA Prohibited List. | Prohibited |
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Profile
Primary Motivation
Evidence Basis
Fit
Section 03
How Kisspeptin Works
Kisspeptin sits at the very top of the hypothalamic-pituitary-gonadal (HPG) axis. It does two related things at once: it switches on the hormonal cascade that produces your own sex hormones, and it modulates the brain circuits that handle sexual and emotional processing. Both arms have been measured in humans.
GnRH Neuron Activation
Kisspeptin binds GPR54 (KISS1R) on GnRH neurons in the hypothalamus and makes them fire. This is the upstream trigger of the entire reproductive axis, the step everything downstream depends on.
LH, FSH, and Sex Hormones
Once GnRH is released, the pituitary secretes LH and FSH, which drive the gonads to produce testosterone in men and estrogen and progesterone in women. Kisspeptin amplifies your own production rather than replacing it.
Sexual and Emotional Brain Processing
In the Imperial College London imaging trials, kisspeptin changed activity in limbic and sexual-processing brain networks versus placebo, and correlated with measures of reward, drive, and reduced sexual aversion. The desire effect is not only hormonal, it is also central.
Measured Physiological Response
In the 2023 trial in men with low sexual desire, kisspeptin increased penile tumescence in response to sexual stimuli by up to 56 percent more than placebo. That is an objective physiological signal, not just a questionnaire score.
Section 04
What the Evidence Shows
This is where kisspeptin earns its place. The human record is real and it comes from one well-published academic group. Here it is in order, with the limitations stated alongside the wins.
| Study | Design | Key Finding | Strength |
|---|---|---|---|
| Prague & Dhillo 2015 [1] | Review of human kisspeptin pharmacology | Subcutaneous or intravenous kisspeptin potently stimulates LH and gonadotropin release in healthy men and women. Establishes the axis effect. | Mechanistic Review |
| Comninos 2017 (J Clin Invest) [2] | Double-blind RCT, 29 healthy men | Kisspeptin enhanced limbic brain activity to sexual and bonding stimuli, correlated with reward and drive, and attenuated negative mood versus placebo. | Randomized, Imaging |
| Comninos 2018 (JCI Insight) [3] | Double-blind crossover RCT, healthy men | Kisspeptin modulated resting brain connectivity and networks tied to sexual and emotional function, and predicted reduced sexual aversion. | Randomized, Imaging |
| Thurston 2022 (JAMA Netw Open) [4] | Double-blind crossover RCT, 32 women with HSDD | Kisspeptin modulated sexual and attraction brain processing and correlated with reduced sexual aversion. Well tolerated, no reported adverse effects. | Randomized, Patients |
| Mills 2023 (JAMA Netw Open) [5] | Double-blind crossover RCT, 32 men with HSDD | Kisspeptin modulated sexual brain processing, increased penile tumescence to sexual stimuli by up to 56% over placebo, and raised behavioral desire measures. | Randomized, Patients |
Study
Design
Key Finding
Strength
Study
Design
Key Finding
Strength
Study
Design
Key Finding
Strength
Study
Design
Key Finding
Strength
Study
Design
Key Finding
Strength
Section 05
Realistic Expectations
Kisspeptin is a reproductive-axis molecule, so most home protocols run it on a recurring schedule rather than as a single on-demand shot. Set expectations as a building effect over weeks, with the honest caveat that the durable real-world timeline is less well-characterized than the acute brain data.
Settling In
Early on, the goal is tolerance and routine. Some users report a subtle lift in interest or mood, but the acute effects measured in trials were on brain activity and hormone levels, not a dramatic same-day sensation. Absence of a big day-one effect is normal.
Axis and Desire Signals
This is the window where responders tend to notice changes in desire and arousal as the reproductive axis is repeatedly stimulated. Individual response varies widely, and hormone status going in matters.
Course Assessment
The catalog protocol runs 8 to 12 weeks. By this point you and your prescriber should be able to judge whether desire and arousal have meaningfully shifted, and decide whether to cycle off, continue, or stop.
Cycle or Reassess
Kisspeptin may be cycled or extended under physician direction. Because it drives a hormonal axis, periodic review of how you feel and, where relevant, hormone levels is the responsible way to run it long term.
Section 06
Dosing Protocol
Trial dosing and practical home dosing differ in route. The published trials used intravenous kisspeptin-54 infusions to study mechanism. Home protocols use subcutaneous injection. Your RxPepsDirect physician sets and titrates the dose for you.
| Context | Dose | Route / Frequency | Evidence Basis |
|---|---|---|---|
| Imperial Trials (Mechanism) | 1 nmol/kg/h kisspeptin-54 | Intravenous infusion, ~75 minutes, in a scanner | Research Setting |
| RxPepsDirect Standard | 20 units (0.2 mg) | Subcutaneous, once daily | Clinical Practice |
| Course Length | 8 to 12 weeks | Daily, then physician review | May Be Cycled |
| Pregnancy | None | Contraindicated, do not use | Hard Stop |
Context
Dose
Route / Frequency
Evidence Basis
Context
Dose
Route / Frequency
Evidence Basis
Context
Dose
Route / Frequency
Evidence Basis
Context
Dose
Route / Frequency
Evidence Basis
The standard start is 20 units, which equals 0.2 mg at the 1 mg/mL concentration Optimal Balance Pharmacy ships. That is a 0.2 mL draw. Inject subcutaneously into abdominal fat with a standard insulin syringe (28 to 31 gauge, 6 to 8 mm needle) and rotate sites. Because kisspeptin acts on the reproductive axis rather than a meal-linked pathway, timing is flexible. Many patients dose at a consistent time each day for routine. Your prescriber decides whether to hold at the starting dose or adjust based on your response.
Section 07
Ready to Inject
0
Reconstitution steps required
503A
Licensed pharmacy (Optimal Balance), physician-supervised
Overnight
FedEx shipping in a reusable cooled travel case
Section 08
Safety and Contraindications
Across the published human trials, kisspeptin was well tolerated, with the women's HSDD trial reporting no adverse effects. The critical safety points are not about acute tolerability, they are about who should not take it at all and what to monitor.
| Consideration | Detail | Action |
|---|---|---|
| Pregnancy | Kisspeptin is a central reproductive driver and is naturally very high in pregnancy | Contraindicated. Use reliable contraception if you could become pregnant. |
| Current hormone therapy | Kisspeptin stimulates your own LH, FSH, and sex hormones | Tell your prescriber about any testosterone, estrogen, or fertility treatment so dosing can be coordinated. |
| Hormone monitoring | It works by moving the reproductive axis | Your prescriber may check hormone levels before and during a longer course. |
| Injection site reaction | Mild, as with any subcutaneous peptide | Rotate sites. Let the vial warm slightly before injecting. |
| Anti-doping tested athletes | Testosterone-stimulating peptide, named on the WADA Prohibited List (2024) | Assume prohibited. Confirm with your governing body before use. |
Consideration
Detail
Action
Consideration
Detail
Action
Consideration
Detail
Action
Consideration
Detail
Action
Consideration
Detail
Action
Section 09
Stacking
Pairs Well With
PT-141 (Bremelanotide)
Different level of the same goal. Kisspeptin works upstream on the reproductive axis and brain processing; PT-141 is on-demand melanocortin arousal. A common sexual-health pairing, coordinated by your prescriber.
Oxytocin
The bonding and connection layer alongside the desire and axis layer. Different mechanism, no direct conflict. Often used together for a more complete intimacy approach.
Avoid or Use Caution
Pregnancy or possible pregnancy
Hard contraindication. Kisspeptin is a central reproductive driver and is already very high in pregnancy. Do not combine with any attempt to conceive without explicit reproductive-medicine guidance.
Unsupervised hormone therapy
Stacking kisspeptin onto testosterone or estrogen without telling your prescriber can push the axis in ways that are hard to interpret. Coordinate, do not freelance.
Section 10
Pricing
Pharmacy: Medication
$80 per 5 mg vial. Compounded and shipped by Optimal Balance Pharmacy, a 503A licensed compounding pharmacy. Pre-reconstituted at 1 mg/mL, FedEx overnight.
Medical Service: Physician Consultation
$39 medical visit fee. Intake consultation including history and pregnancy-risk screening, protocol design, prescription writing, and follow-up. Billed by RxPepsDirect for the medical service only.
Section 11
Legal Access in 28 States
503A Licensed Pharmacy
Optimal Balance Pharmacy, U.S. licensed
Physician Prescription Required
Compounded medication, Rx only
Investigational Compound
Human trial data, no FDA approval
Off-Label, Legal Practice
Standard and legal in U.S. medicine
Kisspeptin is an investigational peptide. It has been studied in published human trials but is not FDA-approved for any sexual-health indication. In the United States it is available through 503A patient-specific compounding under a physician prescription. The 503A pathway is the documented legal route for compounded peptide access. RxPepsDirect prescribers serve patients in 28 states. Separately, note that kisspeptin is named on the WADA Prohibited List, so legal medical access and anti-doping eligibility are two different questions.
Section 12
Community Q&A
Does kisspeptin actually have human evidence?
Yes, which is unusual for a sexual-health peptide. The Imperial College London group ran placebo-controlled brain-imaging trials in healthy men, in women with hypoactive sexual desire disorder, and in men with the same condition. Kisspeptin changed sexual and emotional brain activity versus placebo, and in the 2023 men's trial it also increased penile tumescence. The caveat is that these were short intravenous infusions in a scanner, not a take-home self-injection schedule, so they prove the brain effect more than a durable real-world libido outcome.
How is it different from PT-141?
Different levels. PT-141 is a melanocortin-4 receptor agonist that acts on arousal on demand. Kisspeptin acts further upstream on the reproductive axis: it tells GnRH neurons to fire, raising LH, FSH, and sex hormones, and it also modulates sexual brain processing. PT-141 is fast and on-demand. Kisspeptin is a hormonal-axis molecule used on a recurring schedule.
Can women use it, and is it safe in pregnancy?
Women were studied in the 2022 HSDD trial, so it is not men-only. But it is contraindicated in pregnancy. Kisspeptin drives the reproductive axis and is naturally very high in pregnancy already, so adding more is not appropriate. Anyone who could become pregnant should use reliable contraception and discuss it directly with the prescriber.
Is it banned for athletes?
Treat it as prohibited if you are tested. Kisspeptin and its agonist analogues are testosterone-stimulating peptides, and WADA added kisspeptin as a named example to the Prohibited List in 2024, prohibited in male athletes. Confirm with your governing body and assume it is banned until told otherwise.
How long is a course?
The catalog protocol runs 8 to 12 weeks of daily subcutaneous dosing, and it may be cycled or extended under physician direction. Your prescriber reassesses before any extension or repeat.
Section 13
The RxPepsDirect Model
Pharmacy: Optimal Balance, 503A Licensed
Optimal Balance Pharmacy compounds your kisspeptin under a patient-specific prescription, USP <797> sterile standards, and federal 503A oversight.
Medical Service: RxPepsDirect Physicians
A licensed physician reviews your history, screens for contraindications, designs your protocol, and writes your prescription. RxPepsDirect bills the $39 medical visit fee for this service.
Transparent Safety Communication
This guide flags that the human evidence is short-infusion imaging data rather than long-term take-home outcomes, that there is no FDA approval, that pregnancy is a hard contraindication, and that kisspeptin is on the WADA Prohibited List. We do not hide limitations to make a sale.
Legal Access in 28 States
Every shipment is a compounded prescription medication filled by a 503A licensed pharmacy under a physician prescription.
References
- Prague JK, Dhillo WS. Potential Clinical Use of Kisspeptin. Neuroendocrinology. 2015. PMID: 26277870
- Comninos AN, Wall MB, Demetriou L, et al. Kisspeptin modulates sexual and emotional brain processing in humans. J Clin Invest. 2017. PMID: 28112678
- Comninos AN, Demetriou L, Wall MB, et al. Modulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functions. JCI Insight. 2018. PMID: 30333302
- Thurston L, Hunjan T, Ertl N, et al. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2022. PMID: 36287566
- Mills EG, Ertl N, Wall MB, et al. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2023. PMID: 36735255
Related protocol guides
Other protocols in the same clinical territory. Each guide is co-bylined by a licensed RxPepsDirect prescriber.
MC4R agonist (sexual health)
PT-141 (bremelanotide) protocol guide: MC4R mechanism, dosing, and the nausea reality
The only FDA-approved on-demand HSDD treatment. 40 percent nausea at the fixed Vyleesi dose, MC4R tachyphylaxis, the male evidence gap, and why compounded titration matters.
Pair-bonding nonapeptide hormone
Oxytocin protocol guide: bonding peptide biology, troche vs nasal, and the context-dependent effect
FDA-approved as Pitocin since 1953 for obstetric use. Off-label sublingual and intranasal for bonding and anxiety. Pregnancy is a hard contraindication.
Continue reading